3-4536622-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001378452.1(ITPR1):​c.163+15528T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.445 in 152,096 control chromosomes in the GnomAD database, including 16,943 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.45 ( 16943 hom., cov: 33)

Consequence

ITPR1
NM_001378452.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.57

Publications

11 publications found
Variant links:
Genes affected
ITPR1 (HGNC:6180): (inositol 1,4,5-trisphosphate receptor type 1) This gene encodes an intracellular receptor for inositol 1,4,5-trisphosphate. Upon stimulation by inositol 1,4,5-trisphosphate, this receptor mediates calcium release from the endoplasmic reticulum. Mutations in this gene cause spinocerebellar ataxia type 15, a disease associated with an heterogeneous group of cerebellar disorders. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]
ITPR1 Gene-Disease associations (from GenCC):
  • aniridia-cerebellar ataxia-intellectual disability syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, Orphanet, ClinGen
  • spinocerebellar ataxia type 29
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, G2P
  • spinocerebellar ataxia type 15/16
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001378452.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.685 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001378452.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ITPR1
NM_001378452.1
MANE Select
c.163+15528T>C
intron
N/ANP_001365381.1Q14643-1
ITPR1
NM_001168272.2
c.163+15528T>C
intron
N/ANP_001161744.1Q14643-2
ITPR1
NM_001099952.4
c.163+15528T>C
intron
N/ANP_001093422.2Q14643-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ITPR1
ENST00000649015.2
MANE Select
c.163+15528T>C
intron
N/AENSP00000497605.1Q14643-1
ITPR1
ENST00000354582.12
TSL:5
c.163+15528T>C
intron
N/AENSP00000346595.8A0A3F2YNW8
ITPR1
ENST00000648266.1
c.163+15528T>C
intron
N/AENSP00000498014.1A0A3B3IU04

Frequencies

GnomAD3 genomes
AF:
0.445
AC:
67645
AN:
151978
Hom.:
16914
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.691
Gnomad AMI
AF:
0.448
Gnomad AMR
AF:
0.290
Gnomad ASJ
AF:
0.385
Gnomad EAS
AF:
0.264
Gnomad SAS
AF:
0.361
Gnomad FIN
AF:
0.412
Gnomad MID
AF:
0.453
Gnomad NFE
AF:
0.359
Gnomad OTH
AF:
0.421
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.445
AC:
67725
AN:
152096
Hom.:
16943
Cov.:
33
AF XY:
0.441
AC XY:
32758
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.691
AC:
28672
AN:
41474
American (AMR)
AF:
0.289
AC:
4424
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.385
AC:
1335
AN:
3466
East Asian (EAS)
AF:
0.264
AC:
1364
AN:
5172
South Asian (SAS)
AF:
0.361
AC:
1739
AN:
4816
European-Finnish (FIN)
AF:
0.412
AC:
4357
AN:
10580
Middle Eastern (MID)
AF:
0.446
AC:
131
AN:
294
European-Non Finnish (NFE)
AF:
0.359
AC:
24401
AN:
67980
Other (OTH)
AF:
0.424
AC:
894
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1765
3530
5295
7060
8825
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
592
1184
1776
2368
2960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.383
Hom.:
52690
Bravo
AF:
0.448
Asia WGS
AF:
0.283
AC:
983
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.61
DANN
Benign
0.53
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs304051;
hg19: chr3-4578306;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.